Target intelligence / Profile preview

LON peptidase N-terminal domain and ring finger 2 pseudogene 1 (LONRF2P1)

Target
LONRF2P1
Molecular classification
Pseudogene
01

Overview

LONRF2 pseudogene 1 (LONRF2P1), also known as "LON peptidase N-terminal domain and ring finger 2 pseudogene 1," is classified as a pseudogene, indicating it is a non-protein-coding segment of DNA that resembles the functional paralog LONRF2 but does not encode an active protein product[3][10]. Pseudogenes typically originate through gene duplication or retrotransposition events and often accumulate mutations that disrupt their coding capacity[6]. While some pseudogenes can have regulatory roles at the DNA or RNA level influencing gene expression, there is currently no scientific evidence supporting a direct therapeutic, enzymatic, receptor, or transporter target role for LONRF2P1 specifically[3][6][10]. The canonical, functional gene LONRF2 encodes a ubiquitin ligase involved in protein quality control and neurodegeneration, but LONRF2P1 lacks established protein- or disease-related functionality[1][7][10]. No interacting drugs, mechanisms of action, or clinical utility for biomarker or safety monitoring are documented for this pseudogene.

Other names
LONRF2 pseudogene 1LONRF2P1LON peptidase N-terminal domain and ring finger 2 pseudogene 1
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on LON peptidase N-terminal domain and ring finger 2 pseudogene 1 (LONRF2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LON peptidase N-terminal domain and ring finger 2 pseudogene 1 (LONRF2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call